LifeCell launches “BabyShield” Newborn screening

The world’s most advanced and non-invasive screening program

banner

Mumbai, October 22, 2012:

LifeCell International, India’s largest and most accredited stem cell storage company, today announced the launch of LifeCell  Diagnostics, the world’s most advanced and non-invasive newborn screening program. Specifically the LifeCell  Diagnostics service can identify over 118 health conditions at birth making it the most advanced newborn screening service in the world. Importantly this test is done entirely in a non-invasive manner thereby making it safe for the baby and simple to implement in a healthcare setting. Newborn screening is recognized by health experts as an essential medical test as it can help identify children who may be born with such conditions even before they become sick so that early and preventive treatment can be initiated in order to safeguard them from severe harm such as mental retardation, physical abnormalities, bone deformity, liver dysfunction or even death.

The LifeCell  Diagnostics screening program is performed on a few drops of blood collected from the baby’s umbilical cord at birth and also urine sample retrieved after 48 hours of the baby’s birth. The test results are available within a few days of samples arriving at the lab and this aids early diagnosis and timely treatment thereby improving a child’s chances of living a healthy and normal life. Speaking at the occasion, Dr. James Shoemaker, Associate Professor, Edward A. Doisy Research Center Department of Biochemistry and Molecular Biology , Saint Louis University School of Medicine, USA who was in India specially to launch LifeCell  Diagnostics Program said, “Giving birth to a baby is one of the most exciting and rewarding moment for parents. However, at times the child may be prone to life-threatening diseases which if undiagnosed at an early stage can lead to a lifetime of regret. Newborn screening is recommended by medical councils across the world and is mandatory for all babies born in several countries including the UK, USA, Germany, Japan and Australia. I strongly recommend all parents to invest in a screening at birth, as prevention is always better than cure. LifeCell  Diagnostics is a simple, safe and a non-invasive secure service that causes absolutely no harm to the baby.”

Dr. Kishore Pratap Sanghvi, President, National Neonatology Forum (NNF), Mumbai who was present at LifeCell  Diagnostics launch commented that “Newborn screening is important as it helps to identify genetic disorders that can be treated early thereby preventing future complications. In normal circumstances, infants suffering from these disorders may not show any symptoms until the disease progresses and the symptoms finally surface. Often in such cases it may be too late to prevent severe consequence such as mental retardation, physical abnormalities, developmental delay, poor growth and behavior problems etc. It is therefore extremely important to create awareness about the criticality of newborn screening as it enables early intervention and treatment and facilitates the overall growth and development of the child”.

According to Mayur Abhaya, President & Executive Director, LifeCell International, “LifeCell  Diagnostics is a revolutionary development in field of newborn screening allowing for a completely pain-free and comprehensive way of safeguarding infants against any diseases in the future. At a nominal one time investment of Rs. 4,990, parents can relax peacefully knowing that their child will grow to be healthy and normal. We are extremely pleased to launch this facility across 100 cities in India.”

To avail this service, all parents need to do is to register at the time of pregnancy and LifeCell  Diagnostics will take it from there, promising every child the right start from the time of their birth.

About LifeCell  Diagnostics :

LifeCell  Diagnostics is world’s most comprehensive and non-invasive newborn screening service. LifeCell  Diagnostics Newborn screening program can help identify over 118 conditions at birth which if left undetected could manifest in the future to serious disorders and affect your baby growth or development milestones causing a serious threat to the baby’s health and well-being. LifeCell  Diagnostics newborn screening is done using the baby’s umbilical cord blood sample at birth and the urine sample 48 hours after birth. More details on this service is available at www.babyshield.com . LifeCell  Diagnostics is brought to you by LifeCell – India’s largest and most accredited stem cell bank. For more information on LifeCell please visit www.lifecellinternational.com

About LifeCell International :

LifeCell is India’s largest & most accredited stem cell bank and the first to bring the revolutionary concept of umbilical cord stem cell banking to India in 2004 in technological collaboration with Cryo-Cell International. USA -the world’s first private stem cell bank. LifeCell is headquartered at Chennai with an advanced laboratory & research facility in adherence to strict International guidelines. The stringent standards followed by LifeCell have received many International accreditations from AABB (American Association of Blood Banks), CAP (College of American Pathologists), and NABL (National Accreditation Board for Calibration and Testing Laboratories). LifeCell is the first stem cell bank in India to receive prestigious AABB accreditation for Cord blood & cord tissue. Importantly LifeCell is also the second in the world to be accredited for cord tissue preservation. Since inception LifeCell has grown at a consistent pace and has strongly established its leadership position in the industry, with its coverage extending to over 100 cities and towns in India. As leaders LifeCell had the responsibility of educating the public and medical fraternity on stem cell technology and through these efforts today over 50,000 parents have preserved their baby’s cord blood stem cells with LifeCell. Considering LifeCell’s leadership position and growth, the company was honored as one amongst ‘India’s Most Promising Brand’ for 2011-2012 by 4Ps Business and Marketing. The company is also championing several initiatives in the stem cell therapy area through partnerships and in-house R&D efforts. LifeCell is the sole distributor for USFDA approved point-of-care medical device that can provide a patient’s stem cells from the bone marrow within 15 minutes from by the bed-side, which is useful for applications in orthopedic, vascular and cardiovascular specialties. With these significant achievements and leadership, LifeCell has uniquely positioned itself as a comprehensive stem cells solutions provider with a complete spectrum of services in stem cells through multi-service stem cell banking, R&D, clinical trials and stem cell therapy.

For more information log onto: www.lifecellinternational.com

Media Contacts:

LifeCell International

V. Ravi Shankar,

Head – Corporate Communications & Marketing ravishankar.v@lifecellinternational.com Handphone: 096770 03344

Edelman India

Pallavi Walia / Shruti Bose